Kisho

Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy

liver inflammatory myofibroblastic tumor News | Kisho

Kisho

Not rare diseases news,
news about your rare disease.

Earlier

A recent study published in PubMed highlights the use of FDG-PET/CT for detecting inflammatory myofibroblastic tumors in the testis, showcasing a rare presentation of this neoplasm. This research contributes to the understanding of diagnostic approaches for rare tumors.

A recent study highlights the diagnostic challenges posed by primary inflammatory myofibroblastic tumors of the breast during aspiration cytology. This research underscores the need for heightened awareness among pathologists to avoid misdiagnosis.

Not rare diseases news,news about your rare disease.

Earlier

A recent study published in PubMed highlights the use of FDG-PET/CT for detecting inflammatory myofibroblastic tumors in the testis, showcasing a rare presentation of this neoplasm. This research contributes to the understanding of diagnostic approaches for rare tumors.

A recent study highlights the diagnostic challenges posed by primary inflammatory myofibroblastic tumors of the breast during aspiration cytology. This research underscores the need for heightened awareness among pathologists to avoid misdiagnosis.

Not rare diseases news,
news about your rare disease.